ID   ILT-Mat
AC   CVCL_A782
DR   CLO; CLO_0050973
DR   BioSample; SAMN03472321
DR   RCB; RCB0475
DR   RCB; RCB1880
DR   TKG; TKG 0286
DR   Wikidata; Q54897494
RX   PubMed=6088403;
RX   PubMed=7662981;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: RCB; RCB1880; true.
ST   Source(s): RCB=RCB0475
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G015 ! TL-Mat
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 15
//
RX   PubMed=6088403; DOI=10.1002/ijc.2910340213;
RA   Sugamura K., Fujii M., Kannagi M., Sakitani M., Takeuchi M.,
RA   Hinuma Y.;
RT   "Cell surface phenotypes and expression of viral antigens of various
RT   human cell lines carrying human T-cell leukemia virus.";
RL   Int. J. Cancer 34:221-228(1984).
//
RX   PubMed=7662981; DOI=10.1182/blood.V86.6.2350.bloodjournal8662350;
RA   Imada K., Takaori-Kondo A., Akagi T., Shimotohno K., Sugamura K.,
RA   Hattori T., Yamabe H., Okuma M., Uchiyama T.;
RT   "Tumorigenicity of human T-cell leukemia virus type I-infected cell
RT   lines in severe combined immunodeficient mice and characterization of
RT   the cells proliferating in vivo.";
RL   Blood 86:2350-2357(1995).
//